Guardant Health
$5.27 B
Share price
Change (1 day)
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: $5.27 Billion

As of November 2022 Guardant Health has a market cap of $5.27 Billion. This makes Guardant Health the world's 2258th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2022

End of year Market Cap

Year Market cap Change
2022$5.27 B-48.1%
2021$10.16 B-21.09%
2020$12.88 B75.59%
2019$7.33 B127.64%
2018$3.22 B

End of Day market cap according to different sources

On Nov 26th, 2022 the market cap of Guardant Health was reported to be:

$5.23 Billion
by Yahoo Finance
$5.27 Billion
by CompaniesMarketCap
$5.27 Billion
by Nasdaq
$5.27 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$3.51 B-33.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.09 B-22.36%๐Ÿ‡บ๐Ÿ‡ธ USA